Purpose: The aim of this article is to determine the prevalence of COVID-19 infection among asymptomatic ophthalmic patients undergoing ophthalmic procedures at University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria.
Materials And Methods: A retrospective review of records of all consecutive ophthalmic patients who had pre-operative reverse transcriptase-polymerase chain reaction testing for COVID-19 screening before an elective surgical procedure between July 2020 and January 2021 was done. A semi-structured questionnaire was used to extract the following information from eligible patients' case records: age, gender, results of COVID-19 tests, type of ophthalmic surgical procedure done, and ocular examination findings and diagnosis.
Results: Out of the 150 patients scheduled for surgical procedures within the study period, only 14 (9.3%) returned a positive test result. These patients had their surgeries postponed and were asked to return with negative results 2 weeks later. No association was found between gender, age, or type of surgical procedure and the prevalence of COVID-19 infection.
Conclusion: This study found that 1 in 11 patients scheduled for elective ophthalmic procedure was a carrier of COVID-19 infection, highlighting the need for regular pre-operative testing in order to reduce the risk of spread of infection to healthcare workers and other hospitalized patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380790 | PMC |
http://dx.doi.org/10.4103/jwas.jwas_25_22 | DOI Listing |
Background: Molnupiravir (MOV) is an orally bioavailable ribonucleoside with antiviral activity against all tested SARS-CoV-2 variants. We describe the demographic, clinical, and treatment characteristics of non-hospitalized Danish patients treated with MOV and their clinical outcomes following MOV initiation.
Method: Among all adults (>18 years) who received MOV between 16 December 2021 and 30 April 2022 in an outpatient setting in Denmark, we summarized their demographic and clinical characteristics at baseline and post-MOV outcomes using descriptive statistics.
LGBT Health
January 2025
Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Transgender and nonbinary people (TNB) experienced a disproportionate burden of poor health and socioeconomic outcomes resulting from the coronavirus disease 2019 (COVID-19) pandemic, largely driven by increased vulnerability due to pervasive structural discrimination. To characterize the extent and nature of TNB inclusivity within COVID-19 research, we conducted a scoping review of studies published in English from 2019-2022 reporting COVID-19 pandemic impacts on TNB individuals in the United States. We searched PubMed (PubMed.
View Article and Find Full Text PDFSwiss Med Wkly
December 2024
Center for Primary Care and Public Health (Unisanté), Department of Epidemiology and Health Systems, University of Lausanne, Lausanne, Switzerland.
Aim: To assess the perceptions of adults with diabetes regarding their care and health during the COVID-19 pandemic in the canton of Vaud, Switzerland.
Methods: Cross-sectional data was analysed from the 2021 follow-up questionnaire of the CoDiab-VD survey, a cohort of adults living with diabetes in the canton of Vaud. Various aspects of diabetes care and issues relating to the COVID-19 pandemic were assessed.
Int J Rheum Dis
January 2025
Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Objective: Since COVID-19 infections are more common in systemic lupus erythematosus (SLE) patients, most recent research has focused on the outcome of COVID-19, with fewer studies on disease activity in SLE. This research aims to evaluate flares in SLE with COVID-19 infection while investigating predictive factors.
Methods: A questionnaire survey was conducted to collect information on patients with previously diagnosed SLE from multi-center.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!